期刊文献+

菏泽地区263027例新生儿遗传代谢病筛查及治疗随访情况分析 被引量:3

Analysis of screening and follow-up treatment of genetic metabolic diseases in 263027 neonates in Heze city
原文传递
导出
摘要 目的通过总结菏泽市采用串联质谱技术进行新生儿遗传代谢病筛查情况,分析我市遗传代谢病发病率、疾病种类及治疗随访。方法收集2015年9月—2020年11月菏泽市各县区263027例新生儿足跟血干血片,采用串联质谱技术(非衍生法)进行遗传代谢病筛查,并对遗传代谢病确诊情况、发病率及患儿治疗、预后进行随访分析。结果累积筛查的263027例新生儿中,可疑阳性人数10059例,初筛阳性率为3.8%。经过进一步相关生化指标,共确诊遗传代谢病213例(总患病率为1/1235),其中包括氨基酸代谢病84例(39.4%)、有机酸代谢病105例(49.3%)、脂肪酸氧化障碍疾病24例(11.3%)。结论菏泽地区遗传代谢病病种繁多,发病率明显高于国内其他地区,经过及时针对性的治疗大多预后良好。通过加强新生儿疾病筛查工作及诊治能力,可降低致残率、死亡率,提高患儿生活质量。 Objective To analyze the incidence,disease types and treatment follow-up of genetic and metabolic diseases in Heze city,the newborn genetic metabolic diseases were screened by tandem mass spectrometry.Methods A total of 263027 neonatal heel dried blood samples were collected from Heze from September 2015 to November 2020.The genetic metabolic diseases were screened by tandem mass spectrometry(non derivative method).The diagnosis and incidence of inherited metabolic diseases(IMDs),as well as the treatment and prognosis of the children were analyzed.Results Among 263027 neonates,10059 were suspected to be positive,with a positive rate of 3.8%at first screening.A total of 213 cases(the total prevalence was 1/1235)of IMDs were confirmed by further biochemical indicators,including 84 cases(39.4%)of amino acid metabolic diseases,105 cases(49.3%)of organic acid metabolic diseases,and 24 cases(11.3%)of fatty acid oxidation disorders.Conclusion There are many kinds of diseases and genetic diseases in Heze city,and the incidence rate is much higher than that in other areas of China.Through strengthening neonatal disease screening and diagnosis and treatment ability,the disability rate and mortality can be reduced,and the quality of life of children can be improved.
作者 汪玉锋 WANG Yufeng(Department of Newborn’s Diseases Screening Center,Heze Maternal and Child Health Care Hospital,Heze,Shandong 274000,China)
出处 《中国优生与遗传杂志》 2021年第8期1192-1194,共3页 Chinese Journal of Birth Health & Heredity
关键词 新生儿遗传代谢病筛查 血串联质谱技术 遗传性代谢性疾病 发病率 随访 newborn genetic metabolic diseases screening blood tandem mass spectrometry inherited metabolic diseases incidence follow-up
  • 相关文献

参考文献7

二级参考文献66

  • 1顾学范.新生儿遗传性代谢病筛查的回顾和展望[J].中华儿科杂志,2005,43(5):321-324. 被引量:47
  • 2邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].北京:人民卫生出版社,2011.347.
  • 3Wilcken B, Wiley V, Sim KG, et al. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr,2001,138: 581-584.
  • 4Vijay S, Patterson A, Olpin S, et al. Carnitine transporter defect: diagnosis in asymptomatic adult acylcarnitines in their newborn infants 627-630.
  • 5women following analysis of J Inherit Metab Dis, 2006,29 : Lee NC, Tang NL, Chien YH, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab, 2010,100:46-50.
  • 6Longo N, Amat di San Filippo N, Pasquali M. Disorders of camitine transport and the camitine cycle. Am J Med Genet C Semin Med Genet, 2006,142C :77-85.
  • 7Koizumi A, Nozaki J, Ohura T, et al. Genetic epidemiology of the camitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic camitine deficiency. Hum Mol Genet, 1999,8 : 2247-2254.
  • 8Schimmenti LA, Crombez EA, Schwahn BC,et al. Expanded newborn screening identifies maternal primary carnitine deficiency. Mol Genet Metab, 2007,90 : 441-445.
  • 9Bridget Wilcken, MBChB, FRACP, et al. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr, 2001,581-584.
  • 10Amat di San Filippo C, Pasquali M, Longo N. Pharmacological rescue of camitine transport in primary carnitine deficiency. Hum Mutat, 2006,27:513-523.

共引文献137

同被引文献44

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部